Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN), one of major dose-limiting side effects of first-line chemotherapeutic agents such as paclitaxel, oxaliplatin, vincristine, and bortezomib is resistant to most of existing medicines. The molecular mechanisms of CIPN have not been fully understood. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekiguchi, Fumiko, Kawabata, Atsufumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796379/
https://www.ncbi.nlm.nih.gov/pubmed/33396481
http://dx.doi.org/10.3390/ijms22010367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796379/
https://www.ncbi.nlm.nih.gov/pubmed/33396481
http://dx.doi.org/10.3390/ijms22010367

Ejemplares similares